These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38420013)

  • 21. Prediction of clinical response to neoadjuvant therapy in advanced breast cancer by baseline B-mode ultrasound, shear-wave elastography, and pathological information.
    Wang S; Wen W; Zhao H; Liu J; Wan X; Lan Z; Peng Y
    Front Oncol; 2023; 13():1096571. PubMed ID: 37228493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ratio of intratumour to stromal infiltrating lymphocytes better predicts prognosis in breast cancer.
    Zhang B; Wang X; Cheng C
    Clin Transl Med; 2023 May; 13(5):e1265. PubMed ID: 37218084
    [No Abstract]   [Full Text] [Related]  

  • 23. Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound.
    Zhang H; Cao W; Liu L; Meng Z; Sun N; Meng Y; Fei J
    J Transl Med; 2023 May; 21(1):337. PubMed ID: 37211604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
    van Mackelenbergh MT; Loibl S; Untch M; Buyse M; Geyer CE; Gianni L; Schneeweiss A; Conte P; Piccart M; Bonnefoi H; Jackisch C; Nekljudova V; Tang G; Valagussa P; Neate C; Gelber R; Poncet C; Squifflet P; Saad ED; Heinzmann D; Denkert C; Rastogi P; Cortes J; Guarneri V; de Azambuja E; Cameron D; Ismael G; Wolmark N; Cortazar P;
    J Clin Oncol; 2023 Jun; 41(16):2998-3008. PubMed ID: 37075276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
    Liedtke C; Mazouni C; Hess KR; André F; Tordai A; Mejia JA; Symmans WF; Gonzalez-Angulo AM; Hennessy B; Green M; Cristofanilli M; Hortobagyi GN; Pusztai L
    J Clin Oncol; 2023 Apr; 41(10):1809-1815. PubMed ID: 36989609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer.
    Huppert LA; Gumusay O; Idossa D; Rugo HS
    CA Cancer J Clin; 2023; 73(5):480-515. PubMed ID: 36939293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of immune checkpoint proteins in HPV-infected cervical cancer.
    Zou W; Huang R; Li P; Liu X; Huang Q; Yue J; Liu C
    J Infect Public Health; 2023 Apr; 16(4):542-550. PubMed ID: 36801634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis.
    Wankhede D; Grover S; Hofman P
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell transcriptomic analysis of the role of HPV16-positive macrophages in cervical cancer prognosis.
    Wang S; Li X; Liu C; Yuan Y; Ma F
    J Med Virol; 2023 Jan; 95(1):e28410. PubMed ID: 36519591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer.
    Yang G; Liu P; Zheng L; Zeng J
    Front Surg; 2022; 9():1004687. PubMed ID: 36406359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy.
    Xia X; Wen L; Zhou F; Li J; Lu Q; Liu J; Yu X
    Front Oncol; 2022; 12():967450. PubMed ID: 36313686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
    Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
    Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition change during neoadjuvant chemotherapy for breast cancer.
    Jang MK; Park S; Park C; Doorenbos AZ; Go J; Kim S
    Front Oncol; 2022; 12():941496. PubMed ID: 36091109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of prognostic and predictive biomarkers in breast cancer.
    Tarighati E; Keivan H; Mahani H
    Clin Exp Med; 2023 Feb; 23(1):1-16. PubMed ID: 35031885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer statistics, 2022.
    Siegel RL; Miller KD; Fuchs HE; Jemal A
    CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Microenvironment in Breast Cancer-Updates on Therapeutic Implications and Pathologic Assessment.
    Li JJ; Tsang JY; Tse GM
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition.
    Loi S; Michiels S; Adams S; Loibl S; Budczies J; Denkert C; Salgado R
    Ann Oncol; 2021 Oct; 32(10):1236-1244. PubMed ID: 34311075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers.
    Wang Z; Lin F; Ma H; Shi Y; Dong J; Yang P; Zhang K; Guo N; Zhang R; Cui J; Duan S; Mao N; Xie H
    Front Oncol; 2021; 11():605230. PubMed ID: 33692950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases.
    Xuan L; Sun B; Meng X; Liu C; Cong Y; Wu S
    Cancer Biol Ther; 2020 Nov; 21(11):990-993. PubMed ID: 33121320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
    Kos Z; Roblin E; Kim RS; Michiels S; Gallas BD; Chen W; van de Vijver KK; Goel S; Adams S; Demaria S; Viale G; Nielsen TO; Badve SS; Symmans WF; Sotiriou C; Rimm DL; Hewitt S; Denkert C; Loibl S; Luen SJ; Bartlett JMS; Savas P; Pruneri G; Dillon DA; Cheang MCU; Tutt A; Hall JA; Kok M; Horlings HM; Madabhushi A; van der Laak J; Ciompi F; Laenkholm AV; Bellolio E; Gruosso T; Fox SB; Araya JC; Floris G; Hudeček J; Voorwerk L; Beck AH; Kerner J; Larsimont D; Declercq S; Van den Eynden G; Pusztai L; Ehinger A; Yang W; AbdulJabbar K; Yuan Y; Singh R; Hiley C; Bakir MA; Lazar AJ; Naber S; Wienert S; Castillo M; Curigliano G; Dieci MV; André F; Swanton C; Reis-Filho J; Sparano J; Balslev E; Chen IC; Stovgaard EIS; Pogue-Geile K; Blenman KRM; Penault-Llorca F; Schnitt S; Lakhani SR; Vincent-Salomon A; Rojo F; Braybrooke JP; Hanna MG; Soler-Monsó MT; Bethmann D; Castaneda CA; Willard-Gallo K; Sharma A; Lien HC; Fineberg S; Thagaard J; Comerma L; Gonzalez-Ericsson P; Brogi E; Loi S; Saltz J; Klaushen F; Cooper L; Amgad M; Moore DA; Salgado R;
    NPJ Breast Cancer; 2020; 6():17. PubMed ID: 32411819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.